PTB-101 SDF Alpha

N/A

Report date: 2025/01/26 18:38:32
NME

Base Information

Drug NamePTB-101 SDF Alpha
Drug Alias NameAlpha-1 Antitrypsin (Abeona Therapeutics)SDF AlphaAlpha-1 Antitrypsin (PlasmaTech Biopharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine protease inhibitors
TargetsSerine protease
Therapy Area/IndicationsEmphysema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbeona Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAbeona Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsEmphysema
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A